Sign up to save your podcastsEmail addressPasswordRegisterOrContinue with GoogleAlready have an account? Log in here.
The CEimpact Podcast features two shows: GameChangers Clinical Updates Precept2PracticeGameChangers Clinical Update Series: The GameCha... more
FAQs about CEimpact Podcast:How many episodes does CEimpact Podcast have?The podcast currently has 405 episodes available.
July 06, 2021Aspirin in its Right DoseThe recently published ADAPTABLE study seeks to answer, definitively, a long held question: What is the correct dose of aspirin to improve outcomes in secondary prevention of cardiovascular disease? Also, more information about PCORnet, which is referenced in the article and during the episode, may be found here: https://pcornet.org/Redeem your CPE or CME credit here!We want your feedback! Share your feedback and experience with GameChangers! https://www.jotform.com/build/90155144694964References and resources:Jones WS, Mulder H, Wruck LM, et al. Comparative Effectiveness of Aspirin Dosing in Cardiovascular Disease. N Engl J Med. 2021 May 15. doi: 10.1056/NEJMoa2102137. Epub ahead of print. PMID: 33999548.Continuing Education Information:Learning Objectives: 1. Describe the outcomes and design of the ADAPTABLE study 2. Discuss some of the limitations of this trial in its application to specific patients0.05 CEU | 0.5 HrsACPE UAN: 0107-0000-21-229-H01-P0.50 AMA PRA Category 1 Credits™Initial release date: 7/6/21Expiration date: 7/6/22Complete CPE & CME details can be found here.Follow CEimpact on Social Media:LinkedInInstagram...more19minPlay
June 29, 2021Breathe Easy: Budesonide for COVID-19Vaccines are the mainstay of care in the COVID-19 pandemic. However, patients may still become infected and need treatment options. Two studies have evaluated the role of inhaled budesonide for the early treatment of outpatient COVID-19 infections. Can budesonide hasten the resolution of symptoms or prevent hospitalizations?Redeem your CPE or CME credit here!References and resources:Ramakrishnan S, Nicolau DV, Langford B, et al. Inhaled budesonide in the treatment of early COVID-19 (STOIC): a phase 2, open-label, randomised controlled trial. The Lancet Respiratory Medicine. April 2021. doi:10.1016/s2213-2600(21)00160-0Yu L-M, Bafadhel M, Dorward J, et al. Inhaled budesonide for COVID-19 in people at higher risk of adverse outcomes in the community: interim analyses from the PRINCIPLE trial. medRxiv. Published online January 1, 2021:2021.04.10.21254672. doi:10.1101/2021.04.10.21254672Continuing Education Information:Learning Objective: Identify the appropriate patient population for inhaled budesonide in the treatment of COVID-190.05 CEU | 0.5 HrsACPE UAN: 0107-0000-21-228-H01-P0.50 AMA PRA Category 1 CreditsTM.(the TM needs to be super scripted)Initial release date: 6/29/21Expiration date: 6/29/22Complete CPE & CME details can be found here.Follow CEimpact on Social Media:LinkedInInstagram...more19minPlay
June 22, 2021Gotta Go! The Problem with DiureticsDiuretics, thiazide, and loop are critical medications for a number of disease states. Yet, they are often used inappropriately, either on the wrong dose or schedule or prescribed in patients who may not benefit from diuretics. This episode takes a look at diuretic pearls and how to get the most out of these medications.Resources:Ali S, Jung S, Nandkeolyar S, Stoletniy L, Sakr A, Verbrugge FH, Hilliard A, Abramov D. Inpatient Diuretic Management of Acute Heart Failure: A Practical Review. Am J Cardiovasc Drugs. 2021 Mar 12. doi: 10.1007/s40256-020-00463-5.Sinha AD, Agarwal R. Clinical Pharmacology of Antihypertensive Therapy for the Treatment of Hypertension in CKD. Clin J Am Soc Nephrol. 2019 May 7;14(5):757-764. doi: 10.2215/CJN.04330418.Continuing Education Information:Learning Objective: Identify an appropriate dose and schedule for loop diuretics.0.05 CEU | 0.5 HrsACPE UAN: 0107-0000-21-211-H01-P0.50 AMA PRA Category 1 Credits™.Initial release date: 6/8/21Expiration date: 6/8/22Complete CPE & CME details can be found at: https://network.ceimpact.com/plans/142054?bundle_token=2c8f01a0dd5d1a330a87ed726ba0af93Follow CEimpact on Social Media:LinkedInInstagram...more26minPlay
June 15, 2021Antibiotics in CAP - The Short and the Long of ItLonger antibiotics are associated with increased costs and adverse effects and increase the potential for bacterial resistance. A recent paper in the Lancet describes a study conducted in France comparing the outcomes of patients with community-acquired pneumonia (CAP) who are hospitalized but not critically ill with a short course of antibiotics (3 days) compared to standard treatment (8 days). The study found that the short course was non-inferior to the longer course of antibiotics and may have implications for treating the common infection.References and resources:Dinh A, Ropers J, Duran C, et al. Discontinuing β-lactam treatment after 3 days for patients with community-acquired pneumonia in non-critical care wards (PTC): a double-blind, randomised, placebo-controlled, non-inferiority trial. Lancet. 2021 Mar 27;397(10280):1195-1203. doi: 10.1016/S0140-6736(21)00313-5. PMID: 33773631.Continuing Education Information:Learning Objective: Discuss the difference between 3-day and 8-day antibiotic use in patients with community-acquired pneumonia.0.05 CEU | 0.5 HrsACPE UAN: 0107-0000-21-210-H01-P0.50 AMA PRA Category 1 CreditsTMInitial release date: 6/1/21Expiration date: 6/1/22Complete CPE & CME details can be found at hereFollow CEimpact on Social Media:LinkedInInstagram...more25minPlay
June 01, 2021Live Event on the Pharmacy NetworkReplay of our Live Event Podcast on the Pharmacy Network. Host of GameChangers, Geoff Wall, PharmD, FCCP, BCPS, CGP and Jake Galdo, PharmD talked about season 1 recap, and season 2 new happenings! Season 2 officially launches early June! If you want to watch the live replay, check it out here.Follow CEimpact on Social Media:LinkedInInstagram...more23minPlay
April 27, 2021GameChangers Birthday | GameChangersIt's the GameChangers' Birthday! This episode is a rapid review of a few subjects to celebrate the first year of GameChangers. From oral iron administration to the use of metronidazole with alcohol or serotonin syndrome, this episode has all the ingredients for a celebration!GameChangers' host, Geoff Wall, just released new music! Check out his latest EP here: https://open.spotify.com/artist/0J26ngHZz2cf6mQR3UiEHW?827= or wherever you listen to music!Reference: Stoffel NU, Cercamondi CI, Brittenham G, et al. Iron absorption from oral iron supplements given on consecutive versus alternate days and as single morning doses versus twice-daily split dosing in iron-depleted women: two open-label, randomised controlled trials. Lancet Haematol. 2017 Nov;4(11):e524-e533. doi: 10.1016/S2352-3026(17)30182-5. Epub 2017 Oct 9. PMID: 29032957.Kaundal R, Bhatia P, Jain A, et al. Randomized controlled trial of twice-daily versus alternate-day oral iron therapy in the treatment of iron-deficiency anemia. Ann Hematol. 2020 Jan;99(1):57-63. doi: 10.1007/s00277-019-03871-z. Epub 2019 Dec 6. PMID: 31811360.Visapää JP, Tillonen JS, Kaihovaara PS, et al. Lack of disulfiram-like reaction with metronidazole and ethanol. Ann Pharmacother. 2002 Jun;36(6):971-4. doi: 10.1345/aph.1A066. PMID: 12022894.Orlova Y, Rizzoli P, Loder E. Association of Coprescription of Triptan Antimigraine Drugs and Selective Serotonin Reuptake Inhibitor or Selective Norepinephrine Reuptake Inhibitor Antidepressants With Serotonin Syndrome. JAMA Neurol. 2018 May 1;75(5):566-572. doi: 10.1001/jamaneurol.2017.5144. PMID: 29482205; PMCID: PMC5885255.CPE details for GameChangers Podcast April 2021Learning Objective: Discuss the evidence-based dosing of oral iron supplementation.0107-0000-21-158-H01-P0.2 CEU/2 Hrs (Knowledge)Initial Release Date: 04/06/21Expiration Date: 03/02/24Additional CPE information is located at https://www.ceimpact.com/podcast See omnystudio.com/listener for privacy information.Follow CEimpact on Social Media:LinkedInInstagram...more23minPlay
April 20, 2021You Never Give Me Your Money | GameChangersAlzheimer's Disease and Related Dementias are a terrible disease on individuals, caregivers, and communities. There are no cures. However, new data has come out discussing the risk factors, polypharmacy, and a potential early detection opportunity. It's time to de-prescribe and follow the money.Reference: Nicholas LH, Langa KM, Bynum JPW, Hsu JW. Financial Presentation of Alzheimer Disease and Related Dementias. JAMA Intern Med. 2021;181(2):220–227. doi:10.1001/jamainternmed.2020.6432Maust DT, Strominger J, Kim HM, et al. Prevalence of Central Nervous System–Active Polypharmacy Among Older Adults With Dementia in the US. JAMA. 2021;325(10):952–961. doi:10.1001/jama.2021.1195CPE details for GameChangers Podcast April 2021Learning Objective: Discuss if adverse financial outcomes may be a risk factor for future dementia diagnosis.0107-0000-21-158-H01-P0.2 CEU/2 Hrs (Knowledge)Initial Release Date: 04/06/21Expiration Date: 03/02/24Additional CPE information is located at https://www.ceimpact.com/podcast Disclosure: Dr. Galdo is a member of the Board of Directors for the Alabama Chapter of the Alzheimer's Association.See omnystudio.com/listener for privacy information.Follow CEimpact on Social Media:LinkedInInstagram...more37minPlay
April 13, 2021The Good the Bad & the Ugly | GameChangersMore and more vaccines are getting authorization in the United States to prevent COVID-19. However, sometimes a vaccine trial is not always effective. But even failure can provide new insights. Learn about the Janssen COVID-19 vaccine and what happened with the recent Hepatitis C vaccine candidate.This podcast was recorded prior to the joint CDC and FDA statement on the Johnson & Johnson/Janssen COVID-19 vaccine on April 13th. On April 13th, 2021, the CDC and FDA issued a joint statement recommending a pause on the use of the Johnson & Johnson/Janssen COVID-19 vaccine until further notice. Click here for the full statement.Reference: Page K, Melia M, Veenhuis R, et al. Randomized Trial of a Vaccine Regimen to Prevent Chronic HCV Infection. N Engl J Med 2021; 384:541-549. DOI: 10.1056/NEJMoa2023345Fact Sheet for Healthcare Providers Administering Vaccine Emergency Use Authorization of the Janssen COVID-19 Vaccine to Prevent Coronavirus Disease 2019. https://www.fda.gov/media/146304/download CPE details for GameChangers Podcast April 2021Learning Objective: Describe the outcomes of a recently published trial on hepatitis C vaccine candidates.0107-0000-21-158-H01-P0.2 CEU/2 Hrs (Knowledge)Initial Release Date: 04/06/21Expiration Date: 03/02/24Additional CPE information is located at https://www.ceimpact.com/podcast See omnystudio.com/listener for privacy information.Follow CEimpact on Social Media:LinkedInInstagram...more30minPlay
April 06, 2021Don't Stop Me Now | GameChangersThe battle against the COVID-19 pandemic has continued for over a year. The evidence continues to update and change, and more and more people are becoming vaccinated. This episode provides a review of the newest literature including guidance on vaccinated individuals. But, remember, don't stop wearing a mask now!Reference: Interim Public Health Recommendations for Fully Vaccinated People. Centers for Disease Control and Prevention. https://www.cdc.gov/coronavirus/2019-ncov/vaccines/fully-vaccinated-guidance.html.CPE details for GameChangers Podcast April 2021Learning Objective: Describe evidence-based recommendations to mitigate SARS-CoV-2 infections0107-0000-21-158-H01-P0.2 CEU/2 Hrs (Knowledge)Initial Release Date: 04/06/21Expiration Date: 03/02/24Additional CPE information is located at https://www.ceimpact.com/podcast See omnystudio.com/listener for privacy information.Follow CEimpact on Social Media:LinkedInInstagram...more30minPlay
March 30, 2021Aaay, Updates! | GameChangersRecently the American Gastroenterological Society updated their guidelines for treatment for a true medical emergency: gastric and esophageal bleeding. This episode reviews the guidelines and highlights the importance of several changes to management. Today's episode is sponsored by a special CEimpact FREE Law focused webinar:Make sure to save your spot for FREE LIVE LAW CE April 1st. 7PM. https://ceimpact.com/law Reference: Henry Z, Patel K, Patton H, et al. AGA Clinical Practice Update on Management of Bleeding Gastric Varices: Expert Review. Clinical Gastroenterology and Hepatology. 2021. https://www.clinicalkey.com/#!/content/playContent/1-s2.0-S154235652100077X?returnurl=null&referrer=null CPE details for GameChangers Podcast March 2021Learning Objective: Identify appropriate therapy for individuals with variceal bleeds based on the new guidelines0107-0000-21-097-H01-P0.25 CEU/2.5 Hrs (Knowledge)Initial Release Date: 03/02/21Expiration Date: 03/02/24Additional CPE information is located at https://www.ceimpact.com/podcast See omnystudio.com/listener for privacy information.Follow CEimpact on Social Media:LinkedInInstagram...more26minPlay
FAQs about CEimpact Podcast:How many episodes does CEimpact Podcast have?The podcast currently has 405 episodes available.